Synthesis, anti-microbial and anti-inflammatory activities of 18β-glycyrrhetinic acid derivatives

Yang Yang,Qiuyan Zhu,Yingying Zhong,Xiping Cui,Zhengyun Jiang,Panpan Wu,Xi Zheng,Kun Zhang,Suqing Zhao

DOI: https://doi.org/10.1016/j.bioorg.2020.103985

IF: 5.307

2020-08-01

Bioorganic Chemistry

Abstract:<p>Thirteen 18<em>β</em>-glycyrrhetinic acid (<strong>GA</strong>) derivatives were obtained by reduction at C-11 position, oxidation at C-3 position and condensation at C-2 position of <strong>GA</strong>. Anti-microbial activity evaluation indicated that compounds <strong>04</strong>, <strong>05</strong>, <strong>10</strong>, <strong>13</strong> and <strong>14</strong> showed more potent inhibitory activity against <em>Staphylococcus aureus</em> subsp. <em>aureus</em>, <em>Staphylococcus epidermidis</em>, <em>Staphylococcus aureus</em> than <strong>GA</strong>, especially compound <strong>10</strong>, the inhibitory activity against <em>Staphylococcus epidermidis</em> was equaled with <em>Ampicillin</em>. Moreover, <em>in vivo</em> experiments exhibited that compound <strong>10</strong> also has anti-inflammatory effect, which could decrease about 59.69% TPA-induced ear edema of mice with the gavage treatment of 40.0 mg/mL. Immunohistochemistry results revealed that the effect of inhibition was related to inhibition of TPA-induced upregulation of the pro-inflammatory cytokines TNF-α and IL-1β. Furthermore, compound <strong>10</strong> also significantly decreased the expression level of p65 in NF-κB signaling pathway. In general, compound <strong>10</strong>, both with antibacterial and anti-inflammatory activities, was expected to become a promising bio-functional agent.</p>

biochemistry & molecular biology,chemistry, organic

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to improve the antibacterial and anti - inflammatory activities of 18β - glycyrrhetinic acid (GA) by synthesizing its derivatives. Specifically:

1. **Antibacterial activity**: Researchers hope to prepare a series of new 18β - glycyrrhetinic acid derivatives through structural modifications (such as reduction at the C - 11 position, oxidation at the C - 3 position and condensation reaction at the C - 2 position), and evaluate the antibacterial activities of these derivatives against Gram - positive and Gram - negative bacteria. In particular, the antibacterial effects against Gram - positive bacteria such as *Staphylococcus aureus*, *Staphylococcus epidermidis*, and Gram - negative bacteria such as *Escherichia coli* and *Salmonella typhimurium* are tested.

2. **Anti - inflammatory activity**: Researchers also evaluated the anti - inflammatory activities of these derivatives in a mouse ear inflammation model. The specific experimental method is to use 12 - O - tetradecanoylphorbol - 13 - acetate (TPA) to induce mouse ear inflammation, and then observe the effects of different concentrations of GA and its derivatives on ear edema caused by TPA, the expression levels of pro - inflammatory cytokines (such as TNF - α and IL - 1β), and the expression of p65 protein in the NF - κB signaling pathway.

### Main findings
- **Antibacterial activity**: The study found that some derivatives (such as compounds 04, 05, 10, 13 and 14) had significantly enhanced inhibitory effects on Gram - positive bacteria. In particular, compound 10 had an inhibitory effect on *Staphylococcus epidermidis* comparable to that of the positive control drug ampicillin.
- **Anti - inflammatory activity**: Compound 10 showed a significant anti - inflammatory effect in the TPA - induced mouse ear inflammation model. It could significantly reduce ear edema, inhibit the expressions of TNF - α and IL - 1β, and reduce the expression level of p65 protein in the NF - κB signaling pathway.

### Conclusion
The research results show that the 18β - glycyrrhetinic acid derivatives prepared by structural modification have potential dual antibacterial and anti - inflammatory functions. In particular, compound 10 is expected to be developed into a new bio - functional agent with antibacterial and anti - inflammatory activities.